Ankit Patel, MD
Interventional Cardiology · Braselton, GANPI 1801089842
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Shockwave Medical, Inc at 39.7% of the total. Reporting peaked in 2023 at $8,055 and has fallen 91.3% since, to $699 in 2025.
Across 185 payments — averaging $94.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$7K
- Abbott$2K
- Medtronic$2K
- Cardiovascular Systems Inc.$2K
- Abiomed$545
- Cordis US CORP.$512
- plus $4K from 32 others
Across 19 payments — averaging $4240.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shockwave Medical, Inc$58K
- Abbott$23K
What the payments were for
- Consulting fees$8505%
- Speaking & faculty fees$6,60038%
- Travel & lodging$3,55820%
- Food & beverage$6,40837%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 7 | $6,920 |
| Abbott | 18 | $2,219 |
| Medtronic(2 entities) | 20 | $1,900 |
| Cardiovascular Systems Inc. | 8 | $1,757 |
| Abiomed | 6 | $545 |
| Cordis US CORP. | 2 | $512 |
| Boston Scientific | 7 | $358 |
| Actelion Pharmaceuticals US, Inc. | 8 | $300 |
| Novartis | 14 | $285 |
| Edwards Lifesciences | 8 | $260 |
| Amgen | 15 | $255 |
| Biotronik Inc. | 2 | $229 |
| Asahi Intecc USA, Inc. | 1 | $192 |
| AstraZeneca(2 entities) | 10 | $174 |
| Pfizer | 9 | $169 |
| Johnson & Johnson | 7 | $157 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $150 |
| Heartflow, Inc. | 2 | $148 |
| Angiodynamics, Inc. | 2 | $147 |
| Novo Nordisk | 3 | $135 |
| Avinger Inc. | 1 | $119 |
| Philips North America LLC | 1 | $75 |
| Kestra Medical Technology Services, Inc. | 3 | $58 |
| E.r. Squibb & Sons, L.L.C. | 3 | $50 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| Boehringer Ingelheim | 2 | $38 |
| Merck | 2 | $32 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Cardiva Medical, Inc. | 1 | $19 |
| Lexicon Pharmaceuticals, Inc. | 1 | $18 |
| Lantheus Medical Imaging, Inc. | 1 | $18 |
| Chiesi USA, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Livanova USA, Inc. | 1 | $11 |
| Electronic Waveform Lab, Inc. | 1 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$6,760
- Peripheral Orbital Atherectomy System$1,636
- AMPLATZER$1,297
- CoreValve Evolut$923
- BRITE TIP RADIANZ$500
- Impella$405
- IN.PACT Admiral$350
- ASAHI PTCA Guide Wire$192
- COREVALVE EVOLUT R$151
- BioMonitor$150
- Orsiro Mission$150
- PK Papyrus$150
- Acticor 7 VR-T DX$150
- Rivacor 7 DR-T$150
- XACT$149
- AMPLATZER Occluders$147
- GENERAL - THERAPIES$130
- FFRct$129
- PORTICO$128
- UPTRAVI$122
How this compares
$17,433 in reported general payments places this provider in the 70th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 221 | $221,337 |
| XareltoRivaroxaban | 54 | $72,958 |
| EntrestoSacubitril/Valsartan | 33 | $55,093 |
| BrilintaTicagrelor | 49 | $46,549 |
| FarxigaDapagliflozin Propanediol | 42 | $33,228 |
| Repatha SureclickEvolocumab | 25 | $18,812 |
| JardianceEmpagliflozin | 12 | $17,681 |
| Metoprolol Succinate | 354 | $3,792 |
| Atorvastatin Calcium | 422 | $3,673 |
| ClopidogrelClopidogrel Bisulfate | 302 | $3,418 |
| Ranolazine ErRanolazine | 24 | $3,158 |
| Diltiazem 12hr ErDiltiazem Hcl | 14 | $3,070 |
| Carvedilol | 315 | $2,135 |
| Rosuvastatin Calcium | 116 | $1,706 |
| Ezetimibe | 76 | $1,599 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $169 | $221,337221 claims |
| AstraZenecaBrilinta, Farxiga | $174 | $79,77891 claims |
| Johnson & JohnsonXarelto | $157 | $72,95854 claims |
| NovartisEntresto | $285 | $55,09333 claims |
| Boehringer IngelheimJardiance | $38 | $17,68112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 218 interventional cardiology providers in Georgia.
Other interventional cardiology in Braselton
- William NicholsonAtlanta$1000K
- David KandzariAtlanta$982K
- Pradeep YadavAtlanta$656K
- Salvatore ManninoMarietta$275K
- Megan CoylewrightCalhoun$271K
- Paul GuichardMarietta$260K
- Adam GreenbaumAtlanta$238K
- Wissam JaberAtlanta$222K
- Mudassar AhmedGainesville$193K
- Katherine KunkelAtlanta$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.